Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms?

Journal of Investigative Medicine

Volumn 56, Issue 2, 2008, Pages 545-552

  Dursun, Belda ^a   Dursun, Evrim ^b   Capraz, Irfan ^c   Ozben, Tomris ^b   Apaydin, Ali ^c   Suleymanlar, Gultekin ^d  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b Departments of Biochemistry

^c Radiology

^d AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Antioxidant mechanisms; Atherosclerosis; Uremia

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOL; ANTIOXIDANT; THIOL DERIVATIVE;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; KIDNEY DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RISK FACTOR; UREMIA; CAROTID ARTERY; CAROTID ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ANTIOXIDANTS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SULFHYDRYL COMPOUNDS; UREMIA;

EID: 84940322742     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181641ce3     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112-S119.
2. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918-1927.
3. Yao Q, Pecoits-Filho R, Lindholm B, et al. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405-416.
4. Barreto DV, Barreto FC, Carvalho AB, et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005;67:1576-1582.
5. Himmelfard J, Stenvinkel P, IkNzler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62: 1524-1538.
6. Locatelli F, Canaud B, Eckardt KU, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18: 1272-1280.
7. Esterbauer H, Gebicki J, Puhl H, et al. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
8. Halliwell B. Free radicals and antioxidants. A personal view. Nutr Rev. 1994;52:253-265.
9. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E SUPPL.ementation. Nephrol Dial Transplant. 1997;12:2312-2317.
10. Carru C, Deiana L, Sotgia S, et al. Plasma thiols redox status by laser-induced fluorescence capillary electrophoresis. Electrophoresis. 2004;25:882-889.
11. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif. 1998;16:290-300.
12. Gerardi G, Usberti M, Martini G, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104-110.
13. Himmerfard J, Lazarus M, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis. 1991;17:271-276.
14. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Tietz NW ed. Textbook of Clinical Biochemistry. Philadelphia: WB Saunders Company, 1986:1498-1535.
15. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522-2526.
16. Koster JF, Biemond P, Swaak JG. Intracellular and extracellular sulfhydryl levels in rheumatoid arthritis. Ann Rheum Dis. 1986;45:44-46.
17. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170-3175.
18. Aebi HE. Catalase of enzymatic analysis. In: Bergmeyer HU ed. Volume III Enzymes 1: Oxidoreductases, Transferases. Weinheim: VCH Verlagsgesellschaft, 1987:273-285.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
20. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
21. Lerman A, Holmes DR Jr, Bell MR, et al. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
22. Mano T, Masuyama T, Yasamamoto K, et al. Endothelial dysfunction in the early stage of atherosclerosis precedes the appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J. 1996;131:231-238.
23. Kawagishi T, Nishizawa Y, Konishi T, et al. Highresolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820-826.
24. Hamanishi T, Furuta H, Kato H, et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes. 2004;53:2455-2460.
25. Ishimura E, Shoji T, Emoto M, et al. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis. 2001;38(SUPPL. 1):S186-S190.
26. Kennedy R, Case C, Fathi R, et al. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med. 2001;110:198-204.
27. Lindner A, Charra B, Sheppard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697-701.
28. Mouradd JJ, Pannier B, Blacher J, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int. 2001;59:1834-1841.
29. Rossi A, Bonfante L, Giacomini A, et al. Am J Kidney Dis. 1996;27:58-66.
30. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002;61:2187-2192.
31. Zuccheli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol. 1988;8:163-168.
32. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health study: the CHS Collaborative Research Group. Stroke. 1992;23:1752-1760.
33. Go YM, Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation. 2005;111:2973-2980.
34. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002; 348:93-112.
35. Jackson P, Loughrey CM, Lightbody JH, et al. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995;41:1135-1138.
36. Schmidtmann S, Müler M, von Baehr R, et al. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol Dial Transplant. 1991;6(SUPPL. 3):71-74.
37. Dursun E, Ozben T, Suleymanlar G, et al. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med. 2002;40:1009-1013.
38. Lynch SM, Campione AL, Moore MK. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta. 2000;1485:11-22.
39. Andersson A, Hultberg B, Lindgren A. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 2000;151:535-539.